Lavoie Pascal M, Pham Chandra, Jang Kerry L
FRCPC, Department of Pediatrics, Division of Neonatology, Children's and Women's Health Centre of British Columbia, Room 1R47, 4480 Oak St, Vancouver BC, Canada.
Pediatrics. 2008 Sep;122(3):479-85. doi: 10.1542/peds.2007-2313.
The goal was to determine the magnitude of genetic effects on susceptibility and risk factors for bronchopulmonary dysplasia by using the clinically validated National Institutes of Health consensus definition as a demonstrated proxy for long-term respiratory and neurodevelopmental outcomes in extremely low birth weight infants.
We analyzed clinical data from twin pairs born at </=30 completed weeks of gestation in British Columbia, Canada, between 1993 and 2006. Differences in correlations between monozygotic and dizygotic twin pairs and model-fitting approaches were used to quantify the relative contributions of genetic, shared environmental, and nonshared environmental effects.
Among 318 twins of known zygosity, monozygotic twin pair similarities were greater than those observed for dizygotic pairs, which suggests significant heritability for bronchopulmonary dysplasia. Model-fitting analyses confirmed that genetic effects accounted for 82% and 79% of the observed variance in bronchopulmonary dysplasia susceptibility, defined on the basis of the need for supplemental oxygen at 36 weeks or the National Institutes of Health consensus definition, respectively. Variations in rates of hemodynamically significant patent ductus arteriosus were largely accounted for by genetic effects, whereas the observed variability in susceptibility to blood-borne bacterial infections was largely attributable to environmental factors, both common and unique to each infant.
Susceptibility to bronchopulmonary dysplasia and persistence of patent ductus arteriosus are both significantly heritable. Our study strengthens the case for investigating genetic risk stratification markers useful for predicting the most significant long-term respiratory and neurodevelopmental consequences of bronchopulmonary dysplasia in premature neonates.
通过使用经过临床验证的美国国立卫生研究院共识定义,作为极低出生体重儿长期呼吸和神经发育结局的已证实替代指标,来确定基因对支气管肺发育不良易感性和危险因素的影响程度。
我们分析了1993年至2006年在加拿大不列颠哥伦比亚省妊娠≤30周整周出生的双胞胎对的临床数据。利用单卵双胞胎和双卵双胞胎对之间相关性的差异以及模型拟合方法,来量化基因、共享环境和非共享环境效应的相对贡献。
在318对已知合子性的双胞胎中,单卵双胞胎对的相似性大于双卵双胞胎对,这表明支气管肺发育不良存在显著的遗传力。模型拟合分析证实,基因效应分别占基于36周时对补充氧气的需求或美国国立卫生研究院共识定义所确定的支气管肺发育不良易感性观察变异的82%和79%。血流动力学显著的动脉导管未闭发生率的差异在很大程度上由基因效应解释,而观察到的血行细菌感染易感性的变异性在很大程度上归因于环境因素,包括每个婴儿共有的和独特的环境因素。
支气管肺发育不良的易感性和动脉导管未闭的持续存在均具有显著的遗传性。我们的研究强化了调查基因风险分层标志物的理由,这些标志物有助于预测早产儿支气管肺发育不良最显著的长期呼吸和神经发育后果。